Disease The intractable diseases designated by MHLW, Japan
Diseases : 348 - Clinical trials : 43,690 / Drugs : 27,527 - ( DrugBank : 2,441 ) / Drug target genes : 714 - Drug target pathways : 315
| ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients, FY2024 (corrected) |
|---|---|---|---|---|---|
| 34 | Neurofibromatosis [Skin] 💬 "Neurofibromatosis type 1", "NF1", "Recklinghausen disease", "Neurofibromatosis type 2", "NF2" | 179 179 trials | 51 / 106 / 14 / 7 💬 | 259 259 drugs [ 84 84 drugs ] | 90 90 genes 211 pathways | 4165 4,165 patientsAge distribution
|
| 35 | Pemphigus [Skin] 💬 | 130 130 trials | 10 / 35 / 52 / 6 💬 | 159 159 drugs [ 46 46 drugs ] | 28 28 genes 174 pathways | 3133 3,133 patientsAge distribution
|
| 36 | Epidermolysis bullosa [Skin] 💬 "Kindler syndrome" | 197 197 trials | 57 / 110 / 56 / 3 💬 | 223 223 drugs [ 46 46 drugs ] | 53 53 genes 136 pathways | 293 293 patientsAge distribution
|
| 37 | Generalised pustular psoriasis [Skin] 💬 "GPP", "Pustular psoriasis", "Herpetic impetigo" | 95 95 trials | 3 / 31 / 44 / 5 💬 | 62 62 drugs [ 21 21 drugs ] | 21 21 genes 101 pathways | 2340 2,340 patientsAge distribution
|
| 38 | Stevens-Johnson syndrome [Skin] 💬 "SJS", "Mucocutaneous ocular syndrome" | 20 20 trials | 7 / 11 / 3 / 2 💬 | 29 29 drugs [ 10 10 drugs ] | 15 15 genes 100 pathways | 190 190 patientsAge distribution
|
| 39 | Toxic epidermal necrolysis [Skin] 💬 "Toxic epidermal necrosis", "TEN" | 17 17 trials | 3 / 4 / 0 / 1 💬 | 22 22 drugs [ 10 10 drugs ] | 11 11 genes 103 pathways | 84 84 patientsAge distribution
|
| 159 | Xeroderma pigmentosum [Skin] 💬 "XP" | 12 12 trials | 1 / 9 / 1 / 0 💬 | 16 16 drugs [ 5 5 drugs ] | 7 7 genes 17 pathways | 88 88 patientsAge distribution
|
| 160 | Congenital ichthyosis [Skin] 💬 "Keratinopathic ichthyosis", "Epidermolytic ichthyosis", "Superficial epidermolytic ichthyosis", "Harlequin ichthyosis", "Autosomal recessive congenital ichthyosis", "Congenital Ichthyosiform Erythroderma", "Foliate ichthyosis", "Ichthyosis syndrome", "Netherton syndrome", "Sjogren-Larsson syndrome", "Sjögren-Larsson syndrome", "Keratitis-ichtyosis-deafness syndrome", "KID syndrome", "Dorfman-Chanarin syndrome", "Neutral lipid storage disease", "NLSD", "Multiple sulfatase deficiency", "Austin disease", "Austin syndrome", "Recessive X-linked ichthyosis", "RXLI", "X-linked recessive ichthyosis", "Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature", "IBID", "Trichothiodystrophy", "Follicular ichthyosis", "Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome", "CHILD syndrome", "Conradi-Hunermann-Happle syndrome", "Conradi-Hünermann-Happle syndrome", "CHHS" | 63 63 trials | 17 / 27 / 14 / 2 💬 | 93 93 drugs [ 22 22 drugs ] | 21 21 genes 144 pathways | 108 108 patientsAge distribution
|
| 161 | Familial benign chronic pemphigus [Skin] 💬 "Benign familial pemphigus", "Hailey-Hailey disease" | 6 6 trials | 2 / 3 / 0 / 0 💬 | 9 9 drugs [ 3 3 drugs ] | 2 2 genes 29 pathways | 87 87 patientsAge distribution
|
| 162 | Pemphigoid [Skin] 💬 "Bullous pemphigoid", "BP", "Epidermolysis bullosa acquisita", "Acquired epidermolysis bullosa" | 138 138 trials | 3 / 43 / 46 / 10 💬 | 154 154 drugs [ 53 53 drugs ] | 34 34 genes 144 pathways | 4246 4,246 patientsAge distribution
|
| 163 | Idiopathic pure sudomotor failure [Skin] 💬 "Idiopathic acquired systemic anhidrosis", "Acquired idiopathic generalized anhidrosis", "AIGA", "Idiopathic segmental anhidrosis", "Idiopathic pure sudomotor failure", "IPSF", "Sweat gland failure" | 0 - | 0 - | 0 - | 673 673 patientsAge distribution
|
| 166 | Pseudoxanthoma elasticum [Skin] 💬 "PXE" | 21 21 trials | 4 / 14 / 3 / 1 💬 | 30 30 drugs [ 6 6 drugs ] | 5 5 genes 27 pathways | 160 160 patientsAge distribution
|
